FDA cracks down on DMAA - but this is just the start, not the end, of the debate, predicts CRN
date:Apr 28, 2012
own, FDA supplements division boss Dr Daniel Fabricant said:Before marketing products containing DMAA, manufacturers and distributors have a responsibility under the law to provide evidence of the safety of their products. They havent done that and that makes the products adulterated.
Therelease also notes that DMAA is known to narrow the blood vessels and arteries, which can elevate blood pressure and may lead to cardiovascular events ranging from shortness of breath and tightening in the chest

05/04 12:07